SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sun Pharmaceutical Industries
Sun Pharmaceutical Industries
BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 30, 16:30
915.95
-3.25 (-0.35%)
VOLUME 109,336
LIVE
NSE
Jan 30, 16:30
917.75
-2.05 (-0.22%)
VOLUME 1,873,464
News on Sun Pharmaceutical Industries
Select Year: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Sun-Ranbaxy's $4bn merger deal gets USFTC's conditional nod

2.23 pm | 31 Jan 2015 |  Source: CNBC-TV18

Approval subject to divestment of one antibiotic product to avoid anticompetitive impact in the US mkt...

Ranbaxy Labs Q3 revenue may rise 12% to Rs 3236 cr: Poll 

11.15 am | 28 Jan 2015 |  Source: CNBC-TV18

Ranbaxy Laboratories, which will soon become a part of Sun Pharma, will announce its third quarter (October-December) earnings today. Analysts expect ...

Teva to gain post Ranbaxy's exclusivity loss for Nexium 

10.22 pm | 27 Jan 2015 |  Source: CNBC-TV18

Ranbaxy has lost out on its last big drug opportunity in the US market. The US drug regulator has denied the company 180-day exclusivity for the gener...

Look at Cipla, Sun Pharma, Lupin: Pritesh Mehta 

2.01 pm | 27 Jan 2015 |  Source: CNBC-TV18

Pritesh Mehta of IIFL is of the view that one may prefer Cipla, Sun Pharma and Lupin....

Here are top trading ideas from Pritesh Mehta 

12.56 pm | 27 Jan 2015 |  Source: CNBC-TV18

Watch the interview of Pritesh Mehta of IIFL with Sumaira Abidi & Reema Tendulkar on CNBC-TV18, in which he shared his readings and outlook on market ...

Sun Pharma chief expects Ranbaxy deal to be done by mid-Feb

4.54 pm | 25 Jan 2015 |  Source: PTI

Drug major Sun Pharma's top executive Dilip S Shanghvi expects the USD 4-billion Ranbaxy deal to be concluded by middle of next month while stating th...

Prefer IT, pharma stocks: Sharmila Joshi 

3.08 pm | 23 Jan 2015 |  Source: CNBC-TV18

Sharmila Joshi of sharmilajoshi.com is of the view that one may prefer IT, pharma and financial stocks....

Buy Lupin 1500 call, Ranbaxy 700 Call: VK Sharma 

11.13 am | 23 Jan 2015 |  Source: CNBC-TV18

VK Sharma of HDFC Securities recommends buying Lupin 1500 call and Ranbaxy Labs 700 Call....

See opportunity in Sun pharma, Lupin: Sudarshan Sukhani 

4.52 pm | 22 Jan 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that Sun pharma, Lupin and Aurobindo Pharma are opportunities....

Six in Sixty: Stocks you should keep on your radar 

2.49 pm | 22 Jan 2015 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists out stocks that you should focus on – Suzlon, Sun Pharma, Ranbaxy, HUL, ITC, Zee Entertainment, Cairn India, Tata Motor...

Stocks in news: TCS, Kesoram, SpiceJet, Sasken, Den Network

8.24 am | 20 Jan 2015 |  Source: CNBC-TV18

TCS | Kotak Mahindra Bank | Cairn India | SpiceJet | Jet Airways | Den Networks | Sun Pharma | Mindtree | Central Bank of India | Muthoot Finance | YE...

Buy Sun Pharma, advises Sudarshan Sukhani 

9.28 am | 19 Jan 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Sun Pharma and feels that one can also take a position in the stock....

Go long in Nifty, Bank Nifty; buy gold, Bata India: Sukhani 

9.11 am | 19 Jan 2015 |  Source: CNBC-TV18

Defensives are likely to be in focus now because base building seems to be happening over there according to SudarshanSukhani....

Here are top 10 stocks to focus on January 13  

8.55 am | 13 Jan 2015 |  Source: CNBC-TV18

Here are top 10 stocks to focus on January 13 - Cairn India, Jet Airways, Apollo Tyres, Ceat, Crompton Greaves, Bank Nifty, Hindalco, CMC, Clariant Ch...

Buy Sun Pharmaceutical Industries: Pritesh Mehta

3.33 pm | 12 Jan 2015 |  Source: CNBC-TV18

Pritesh Mehta, Senior Technical Analyst at IIFL advises buying Sun Pharmaceutical Industries....

Prefer Axis Bank, Sun Pharma: Gaurang Shah 

3.04 pm | 09 Jan 2015 |  Source: CNBC-TV18

According to Gaurang Shah, VP at Geojit BNP Paribas financial Services, one may prefer Axis Bank, Sun Pharma, BPCL and Tata Motors....

Merck Millipore bets big on India amid regulatory concerns 

9.51 pm | 08 Jan 2015 |  Source: CNBC-TV18

Indian drug makers are finding themselves under the gun as run-ins with global drug regulators are on the rise. This is being seen as a golden opportu...

Global equities to gain about 11% by 2015-end: Citi

8.40 am | 07 Jan 2015 |  Source: CNBC-TV18

Pre-exceptional PAT growth in Q3FY15 for our coverage universe should be 5 percent (ex-Oil PSU), a six quarter low, dragged down by private oil compan...

Credit Suisse’s list of most and least preferred 2015 picks

9.31 am | 05 Jan 2015 |  Source: Moneycontrol.com

India's better medium-term growth outlook for earnings economy should also support the broader market, says Credit Suisse...

Tie-up on cards for Biolight & Sun Pharma? 

10.02 pm | 02 Jan 2015 |  Source: CNBC-TV18

Sources say Sun Pharma could be one of the companies that Biolight is actively talking to. However, Sun Pharma in a statement to CNBC-TV18 says, “We...

1 2 3 4 5 6 7
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.